|
Ravenbhel Healthcare
Pvt. Ltd. is located in Jammu, J&K, India
established in 2003. It is an ISO 9001:2000 and cGMP certified
plant. We carry out contract manufacturing for reputed Indian
MNCs. We ensure a complete quality assurance with timely
delivery of the products. The range of product includes
various innovative tablets, syrups and capsules, which require
an expertise in the pharmaceutical domain.
Mr. Sahil Mahajan (Managing Director) leads
from the front with his highly qualified
formulation team ensuring a speedy product
development and scaling up of the Manufacturing process. We specialize in
minimizing the process steps and hence reducing cost and
wastage of the product.
You can trust us on the quality and schedule that is an
outcome of the quality systems we follow. Proper planning and
documentation of the processes at all steps make the system
robust and error free.
|
|
|
our strength :: |
|
|
People |
Our
Associates |
|
• Qualified M.B.A.
and Pharmacists with an average Age 35 yrs.
•
Total Technical Workforce 48 people
•
Production 15
•
Quality Assurance 14
•
Storage & Distribution 7.
•
Maintenance 6
•
Administration & Support Services 6
|
|
• Sanat |
• Nicholas |
|
• Micro |
• Aristo |
|
• Group |
• Alkem |
|
• Orchid |
• Wanbury |
|
• Zydus |
• Elder |
|
• Cadila Pharma |
• Dyota Numandis |
|
• Torrent |
• Intas |
|
• Emcure |
|
|
|
|
|
|
|
|
Quality
Policy ::
|
|
|
At Ravenbhel, We believe that quality is never
an accident, it is always the result of high
intention, sincere effort, intelligent
direction and skillful execution. Company
attention to quality spans all processes from
sourcing
of raw materials, through production, to the
latest generation packing for optimum purity,
safety, efficacy and stability.
In our pursuit of excellence, we aim at
providing world-class quality standards for
every product that we develop and manufacture.
To achieve this, we deploy elaborate testing
and in-process control procedures, which are
backed by state-of-the-art quality assurance
facilities.
We practice continuous monitoring of services
to maintain the highest standard.
|
|
|
PLANT
CAPACITY ::
|
|
|
TABLETS (90 million/month) |
CAPSULES(1.75 million/month) |
ORAL LIQUIDS (1.2 million bottles/month) |
• Manufacturing all types of latest molecules.
• Manufacturing various formulation types like:
• Dispersible Tablets
• Chewable Tablets
• Sustained Release
• Delayed release
• Pessaries
• Tongue Dissolving |
• Pellets
• Tablet in Capsules
• Sustained Release |
• All Kinds of formulation in syrup/suspension form |
|
|
|
PLANT ::
|
|
|
Beta Blockers Hypolipidaemic Agents
Anti-Hypertensives Macrolides
Diuretics Quinolones
Anti-Anginal Anti-Fungals
Peripheral Vasodilators Anti-Virals
Coagulants Anti-Malarials
Anti-Platelet Protozoal Infestations
Vaso-Pressors Anthelmintics
Opioid Analgesics Sedatives & tranquillizers
Non-Opioid Analgesic Anti-Emetics & Anti-Nauseants
Muscle relaxants Anti-Convulsants
Anti-Diarrhoeals Anti-Migraine
Carminatives Peripheral Neuropathy
Digestive Enzymes H2 Blockers & Ulcer Healing Drugs
Anti-Allergics Urethral vaginal Infections
Uterine stimulants Urinary Tract Analgesics & Anti-Spasmodics
|
|
|
|
